New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.
Več na: https://www.wired.com/story/blood-tests-for-alzheimers-have-arrived-but-how-effective-are-they-and-can-they-really-change-patients-lives/
nazaj
